Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julia Frede

Showing results (11-20 of 23) with videos related to

Pageof 3
Sort By:
Haematologica|May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemiaAmy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Blood Advances|January 15, 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myelomaJohannes M Waldschmidt, Noori Sotudeh, Sankalp Arora, et al.
Cancer Immunology Research|June 27, 2022
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell TherapyNam Gyu Im, Amy Guillaumet-Adkins, Megha Wal, et al.
Blood Cancer Journal|August 28, 2024
B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformationLisa Pfeuffer, Viola Siegert, Julia Frede, et al.
Nature Cell Biology|October 22, 2021
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myelomaJulia Frede, Praveen Anand, Noori Sotudeh, et al.
Nature Communications|November 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemiaCaroline R M Wiggers, Eugene Y Cho, Merve Ozdemir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in <i>BRAF</i>-Mutated Multiple MyelomaJohannes M Waldschmidt, Jake A Kloeber, Praveen Anand, et al.
Leukemia|May 12, 2018
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencingGuangwu Guo, Noopur S Raje, Charles Seifer, et al.
Nature Communications|April 11, 2026
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapyJana Samarin, Hana Nůsková, Piotr Fabrowski, et al.
Leukemia|September 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myelomaJulia Frede, Julia C Poller, Kayleen Shi, et al.
Pageof 3

Showing results (11-20 of 23) with videos related to

Sort By:
Pageof 3
Haematologica|May 7, 2026
Altered immune and treatment response gene expression signatures among povertyexposed children with B-cell acute lymphoblastic leukemiaAmy Guillaumet-Adkins, Elnaz Mirzaei Mehrabad, Noori Sotudeh, et al.
Blood Advances|January 15, 2025
Nivolumab to restore T-cell fitness in CAR-T refractory multiple myelomaJohannes M Waldschmidt, Noori Sotudeh, Sankalp Arora, et al.
Cancer Immunology Research|June 27, 2022
Regulatory Programs of B-cell Activation and Germinal Center Reaction Allow B-ALL Escape from CD19 CAR T-cell TherapyNam Gyu Im, Amy Guillaumet-Adkins, Megha Wal, et al.
Blood Cancer Journal|August 28, 2024
B-cell intrinsic RANK signaling cooperates with TCL1 to induce lineage-dependent B-cell transformationLisa Pfeuffer, Viola Siegert, Julia Frede, et al.
Nature Cell Biology|October 22, 2021
Dynamic transcriptional reprogramming leads to immunotherapeutic vulnerabilities in myelomaJulia Frede, Praveen Anand, Noori Sotudeh, et al.
Nature Communications|November 21, 2025
Remodeling of the immune microenvironment is linked to adverse outcome in pediatric T cell acute lymphoblastic leukemiaCaroline R M Wiggers, Eugene Y Cho, Merve Ozdemir, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 14, 2021
Single-Cell Profiling Reveals Metabolic Reprogramming as a Resistance Mechanism in <i>BRAF</i>-Mutated Multiple MyelomaJohannes M Waldschmidt, Jake A Kloeber, Praveen Anand, et al.
Leukemia|May 12, 2018
Genomic discovery and clonal tracking in multiple myeloma by cell-free DNA sequencingGuangwu Guo, Noopur S Raje, Charles Seifer, et al.
Nature Communications|April 11, 2026
Differential KEAP1/NRF2 mediated signaling widens the therapeutic window of redox-targeting drugs in SCLC therapyJana Samarin, Hana Nůsková, Piotr Fabrowski, et al.
Leukemia|September 19, 2025
The endogenous T cell landscape is reshaped by CAR-T cell therapy and predicts treatment response in multiple myelomaJulia Frede, Julia C Poller, Kayleen Shi, et al.
Pageof 3